The Revenue Rises
  • Politics
  • Stocks
  • Business
  • Economy
Trending Now
S&P 500 Earnings for 2025 Q1 — Still...
Money’s Not Leaving the Market — It’s Rotating!
From Oversold to Opportunity: Small Caps on the...
Tariffs and weaker beer demand are weighing on...
Essence Fest leads a summer of events for...
Pullbacks & Reversals: Stocks Setting Up for Big...
S&P 500 Earnings for 2025 Q1 — Still...
Market Signals Align – Is a Bigger Move...
MACD Crossovers: Why Most Traders Get It Wrong
Should You Buy Roblox Stock Now? Key Levels...

The Revenue Rises

  • Politics
  • Stocks
  • Business
  • Economy
Business

Amazon same-day prescription delivery expanding to nearly half of U.S. in 2025

by admin October 10, 2024
October 10, 2024
Amazon same-day prescription delivery expanding to nearly half of U.S. in 2025

Amazon plans to bring same-day prescription delivery to 20 more cities next year, the company said Wednesday, marking the latest phase of its push into health care.

As part of the expansion, which will make speedy medicine delivery available in nearly half of the U.S., Amazon said, it is embedding pharmacies in same-day delivery facilities often clustered around major metro areas. The company announced its plans during a press event at one of its warehouses near Nashville, Tennessee.

Amazon in March introduced same-day pharmacy delivery in New York and Los Angeles, after launching the service in Indianapolis, Miami, Phoenix, Seattle, and Austin, Texas. Some of the cities that will be added in 2025 include Boston, Dallas, Minneapolis, Philadelphia and San Diego.

The company has worked to accelerate medication deliveries. It’s been testing prescription delivery by drone in one Texas city. In most cases, the company said, when shoppers order same-day delivery of their medication by 4 p.m. they can receive it at home by 10 p.m.

The prescriptions are offered through Amazon Pharmacy, a section of its website and app that allows shoppers to order medication, with free delivery for Prime members. Launched in 2020, Amazon Pharmacy was born out of the company’s 2018 acquisition of online pharmacy PillPack. The company in January said it had doubled the number of customers it serves in the past year, though it didn’t provide a specific number.

It faces competition from traditional pharmacies such as CVS and Walgreens, as well as other large retailers that offer pharmacy services, such as Walmart. Amazon said Wednesday it’s capitalizing on the care gaps created by the growing number of “pharmacy deserts” in the U.S., which can limit a patient’s access to medications and pharmacist care. Chain stores such as Walgreens and CVS have shuttered hundreds of locations recently as they struggle to maintain profitability.

Amazon’s online pharmacy is a part of the company’s multiyear effort to make inroads in the health-care industry. The company acquired primary care provider One Medical for roughly $3.9 billion in July 2022. It launched then shuttered its telehealth service, Amazon Care, along with a line of health and wellness devices.

This post appeared first on NBC NEWS

previous post
Oil Prices Soar Amid Middle East Tensions – What’s Next for Gas Prices?
next post
Is the Trump campaign’s male-dominated culture losing women votes?

Related Posts

Where are low-cost airlines cutting back now? New...

September 3, 2024

Comcast to announce the spinoff of cable networks,...

November 21, 2024

Citadel’s Ken Griffin buys a stegosaurus for $45...

July 19, 2024

Ford and Mazda issue do-not-drive warnings for 457,000...

August 14, 2024

GameStop, MicroStrategy shares rise after Ryan Cohen posts...

February 11, 2025

Frontier Airlines proposes merging with fellow budget carrier...

January 30, 2025

Women’s Tennis Association extends media rights deal with...

June 27, 2025

The fight for the future of the Murdoch...

September 11, 2024

Uber delivery chief Gore-Coty is leaving after almost...

June 4, 2025

OpenAI introduces Operator to automate tasks like vacation...

January 24, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • S&P 500 Earnings for 2025 Q1 — Still Overvalued
    • Money’s Not Leaving the Market — It’s Rotating!
    • From Oversold to Opportunity: Small Caps on the Move
    • Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands
    • Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

    Popular Posts

    • 1

      Polls show some good early signs for Kamala Harris

      July 26, 2024
    • 2

      Solana and Cardano: Solana is waiting for a new impulse

      July 18, 2024
    • 3

      The presidential race shifts — modestly, so far — toward Harris

      August 6, 2024
    • 4

      Donald Trump’s imaginary and frightening world

      September 23, 2024
    • 5

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

      June 4, 2025

    Categories

    • Business (729)
    • Economy (975)
    • Politics (873)
    • Stocks (867)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: therevenuerises.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 The Revenue Rises. All Rights Reserved.